Ocugen Inc
Ocugen Inc (OCGN) Implied Volatility Current
OCGN implied volatility is 91%. IV Rank is 8%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking OCGN implied volatility helps you identify when options premiums on Ocugen Inc are historically cheap or expensive, and where the best trades are hiding. Ocugen Inc implied volatility reflects the market's expectation of future price movement: when OCGN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Ocugen Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For OCGN, tracking metrics like OCGN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on OCGN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD.
Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where OCGN implied volatility sits today versus where it has been. Our scanner ranks Ocugen Inc implied volatility against its historical range, surfaces extremes in OCGN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Ocugen Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track OCGN IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→